CannabisNewsBreaks Archive - Page 14 of 428

WednesdayFeb 21, 2024 1:28 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) to Expand Portfolio with Strategic Acquisition

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a leading holding company in the cannabis industry, today announced final stages of negotiations to acquire its sixth cannabis company in Colombia. The acquisition is extremely significant because of the company’s cannabis genetics license, which MedCana believes will revolutionize its potential to create and register unique cannabis genetic varieties for production and commercialization. “The addition of this new company to MedCana’s portfolio represents a significant leap forward in our commitment to innovation and excellence within the cannabis sector,” said Gabriel Diaz, CEO of MedCana. “By integrating this company’s cutting-edge genetics capabilities, MedCana will…

TuesdayFeb 20, 2024 1:51 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6M Registered Direct Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has closed on a registered direct offering. The offering included the purchase and sale of 1,558,443 shares of common stock (or common stock equivalents in lieu thereof) offered at $2.31 per share. The company also noted that, in a concurrent private placement, it issued unregistered warrants to purchase up to 1,558,443 shares of common stock. The shares were offered at an exercise price of $2.185 per share and were immediately exercisable upon issuance with an expiration date five years following the date of issuance. H.C. Wainwright & Co. acted…

ThursdayFeb 15, 2024 11:44 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on $3.6M Registered Direct Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has entered into definitive agreements. The agreements are for the purchase and sale of 1,558,443 shares of common stock (or common stock equivalents in lieu thereof) offered at $2.31 per share (or per common stock equivalent in lieu thereof). The agreements are part of a registered direct offering priced in adherence with NASDAQ rules. In addition, the company noted that in a concurrent private placement, it will issue unregistered warrants to purchase up to 1,558,443 shares of common stock. Those shares will be offered at an exercise price of…

WednesdayFeb 14, 2024 2:56 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ), Subsidiary Ink Multiyear Deal with Danziger Colombia

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) and its majority-controlled subsidiary, Eko2o Environmental Solutions S.A.S., have signed a multiyear contract with Danziger Colombia. According to the announcement, the agreement outlines plans for Colombia-based Eko2o, a leading provider of greenhouse infrastructure and agricultural technology, to provide greenhouse infrastructure services, irrigation products and technology to Danziger’s flower operations in Colombia. The company anticipates the agreement, which marks a pivotal moment for both organizations in their commitment to innovative agricultural practices, will result in between $2.5 million and $3 million in revenue over the next three years. Eko2o specializes in providing state-of-the-art…

WednesdayFeb 14, 2024 10:49 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Numbers for Q2 2024, Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on its financial results for Q2 2024, the period ended Dec. 31, 2023. The company also provided a corporate update, including plans to advance two preclinical programs in Alzheimer's and age-related macular degeneration. Highlights of the report included that the company closed the 2023 calendar year in a cash position of $9.5 million and with 164% revenue growth in business subsidiary, BayMedica. “This period was another strong operational quarter for the company, as we expanded our pharmaceutical pipeline with…

TuesdayFeb 13, 2024 3:50 pm

CannabisNewsBreaks – IBN’s CNW to Elevate Visibility for ZJ Events in 2024

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 60+ brands within IBN (“InvestorBrandNetwork”), has announced its renewed partnership as the official newswire for ZJ Events in 2024. ZJ Events, an innovative organizer hosting multiple trade shows across the USA and South America every year, is set to deliver a captivating 2024 event series, featuring the BizCann Expo and Alternative Products Expo, the nation’s largest CBD and hemp event (formerly known as USA CBD Expo). Leveraging its extensive array of corporate-communications solutions, IBN aims to elevate the visibility of exhibitors, participants and the conferences among…

TuesdayFeb 13, 2024 1:11 pm

CannabisNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Releases Q2 2024 Financial Report

Astrotech (NASDAQ: ASTC), an innovative science and technology company, is releasing its financial results for Q2 2024, the period ended Dec. 31, 2023. Highlights of the report include a 512% increase in year-to-date revenue, which reached $1,540,000 compared to $301,000 in the same period in 2023; a strong consolidated balance sheet with $37 million in cash and liquid investments; and a year-to-date FY 2024 gross margin increase of 46% from 38% during the same period in 2023. In addition, the company reported that its 1st Detect subsidiary reentered detection and nondetection testing with the U.S. Transportation Security Administration (“TSA”) for cargo…

MondayFeb 12, 2024 3:39 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Improves Delivery of GLP-1 Drug to Bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, announced the final results from its completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). “Most notable from its pilot study was the improved delivery of semaglutide to the bloodstream, which significantly improved blood sugar control. For one, in just 20 minutes after oral administration, the DehydraTECH-GLP-1 blood semaglutide level was about 261% higher than that of the control, a statistic that reflected…

MondayFeb 12, 2024 3:02 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) Committed to Building Capabilities to Provide Pharmaceutical-Grade Cannabis Extracts to the World

Software Effective Solutions (OTC: SFWJ) is among companies in the cannabis space paying close attention to the mounting calls for the rescheduling of cannabis to a Schedule III from a Schedule I substance per the Controlled Substances Act (“CSA”). “The call for cannabis rescheduling on the CSA list is not new, but it has gained momentum since the U.S. Department of Health and Human Services (‘HHS’) sent a brief letter to the head of the U.S. Drug Enforcement Administration… ‘HHS is believed to have advised DEA to move marijuana from Schedule I to Schedule III of the Controlled Substances Act…

FridayFeb 09, 2024 1:30 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, has announced the appointment of Netta Jagpal, CPA, CA, as the newest member of its executive team; Jagpal will serve as the company chief financial officer and corporate secretary, effective Feb. 20, 2024. Jagpal has garnered more than two decades of experience in financial leadership roles, primarily in the biotech industry. Most recently, she was vice president of Financial Reporting & Compliance for D-Wave Systems Inc. (NYSE: QBTS), where she was a key player in the company’s initial public offering process;…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks